Results 101 to 110 of about 48,720 (296)

Cerebral complications in diabetic ketoacidosis [PDF]

open access: yes, 2005
Although much is known about diabetic ketoacidosis (DKA) and its treatment, the pathology of cerebral complications in patients who develop ketoacidosis is not yet well understood.
Cizmecioglu, FİLİZ MİNE   +2 more
core   +1 more source

Intravenous Nimodipine Associated Severe Metabolic Acidosis and Haemodynamic Collapse in patient with Aneurysmal Subarachnoid Haemorrhage: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research
Nimodipine is a dihydropyridine Calcium Channel Blocker (CCB) routinely used in the management of aneurysmal Subarachnoid Haemorrhage (aSAH) to prevent Delayed Cerebral Ischemia (DCI).
Rolly Malhotra   +2 more
doaj   +1 more source

Presumed paradoxical embolus in a patient with diabetic ketoacidosis

open access: yes, 2015
Catherine Langevin, Caroline Lamarche, Robert Z Bell, Michel Vallée Department of Nephrology, Maisonneuve-Rosement Hospital, Montreal, QC, CanadaAbstract: Thrombotic complications figure among the most frequent causes of mortality in diabetic ...
Bell RZ   +3 more
core  

Under‐ and overdosing insulin in the hospital: A retrospective cohort study of dose deviation and patient outcomes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Glycaemic abnormalities during hospitalization are common and linked to morbidity and mortality, yet little is known about how deviations from guideline‐recommended insulin dosing affect outcomes. The aim of this study is to examine whether deviation from an expected insulin dose in non‐critically ill hospitalized adults with type 2 ...
Hussein Zaitoon   +5 more
wiley   +1 more source

Embedding psychological care in diabetes services: Why it's time to innovate and integrate

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims This narrative review synthesizes current knowledge on the psychological dimensions of diabetes care, identifies gaps in evidence and practice and proposes innovative pathways for embedding psychological care into routine diabetes services.
Per Winterdijk   +4 more
wiley   +1 more source

Effect of sodium glucose cotransporter 2 inhibition immediately prior to heart transplantation

open access: yesJHLT Open
Sodium glucose cotransporter 2 inhibitors (SGLT2i) are an established treatment for heart failure and type 2 diabetes. Guidelines suggest withholding SGLT2i preoperatively due to the risk of ketoacidosis.
Lisa M. Raven, MBBS, FRACP   +10 more
doaj   +1 more source

Understanding parents' perspectives of repeated blinded continuous glucose monitoring in children with early‐stage type 1 diabetes and an affected first‐degree relative

open access: yesDiabetic Medicine, EarlyView.
Abstract Aim To explore the lived experiences of parents of children at risk of type 1 diabetes (T1D) undergoing repeated blinded continuous glucose monitoring (CGM). Method Since 2021, children with persistent islet autoimmunity in the Environmental Determinants of Islet Autoimmunity (ENDIA) study have been invited to participate in a sub‐study ...
Alexandra S. Tully   +15 more
wiley   +1 more source

Starvation ketoacidosis in pregnancy

open access: yes, 2013
Starvation ketosis outside pregnancy is rare and infrequently causes a severe acidosis. Placental production of hormones, including glucagon and human placental lactogen, leads to the insulin resistance that is seen in pregnancy, which in turn increases ...
Frise, Charlotte J   +3 more
core   +1 more source

Australian healthcare professionals' perspectives and experiences on screening and monitoring islet autoimmunity: A qualitative exploration

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Islet autoantibodies characterise a period of immune‐mediated destruction preceding clinical (symptomatic) type 1 diabetes. Screening and monitoring programmes for islet autoimmunity are being planned and implemented globally. The perspectives and experiences of healthcare professionals working in paediatric screening and monitoring of ...
Mia Majstorovic   +5 more
wiley   +1 more source

Participant and physician perspectives on the use of SGLT2 inhibitors in type 1 diabetes

open access: yesDiabetic Medicine, EarlyView.
Abstract Aims Sodium–glucose co‐transporter inhibitors (SGLT2i) have proven cardiorenal benefits in type 2 diabetes and are promising as adjunct‐to‐insulin therapy in participants with type 1 diabetes (T1D). However, clinical use in T1D has been limited owing to a lack of regulatory approval and the augmented risk of diabetic ketoacidosis (DKA ...
Julia Fielden   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy